Aptadir Therapeutics Raises $45M Seed Funding to Develop Genetic Disease Treatments
Milan-based biotech company Aptadir Therapeutics has raised $45 million in seed funding to develop new treatments for difficult-to-treat genetic diseases. The funding is one of the largest early-stage investments in…